Particularly, patients with dominant proliferative nephritis present anti-dsDNA positivity and a higher risk of damage accrual, while patients with anti-RNP positivity seem to have lower probability of renal involvement and an association with extra-renal manifestations, like myositis and anemia. This evidence concerns the gene RNPC3 and anemia.